Ingredion Incorporated
A global maker of starches and sweeteners, transforming plant-based materials like corn into ingredients used in foods, beverages, and brewing. It traces back to the Corn Products Refining Company, formed in 1906, which gave the world pantry staples like Karo syrup and Mazola corn oil. In 2012 it renamed itself Ingredion—a blend of "ingredients" and a Greek word meaning "something that goes"—to reflect its move toward health-focused ingredients.
10-Q · Quarter ended Jun 30, 2026 · SEC filing ↗
The Argo facility's production challenges deepened, dragging the largest 's profit down 33%. was flat at $1.85 billion, but contracted 3 points to 23% and fell 31% to $188 million, weighed down by higher manufacturing costs and a $45 million charge for closing the Cabo, Brazil plant. The company is now managing a costly operational disruption while carrying the financial risk of a pending $6 billion acquisition.
Q2 2026 net income fell 42% to $114M on higher manufacturing costs, Argo thermal event, Cabo closure charges, and FX hedging losses.
See the discussion set forth in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2025 for a discussion of the manner in which we address risks with respect to raw material and energy co…
See the discussion set forth in Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our Annual Report on Form 10-K for the year ended December 31, 2025 for a discussion of the manner in which we address risks with respect to raw material and energy costs, interest rates, and foreign currencies. Other than the arrangement below, there have been no material changes in the information provided with respect to those risks during the second quarter of 2026. In connection with our pending acquisition of Tate & Lyle, we entered into financial derivative instruments to mitigate exposure to British pound sterling for the cash consideration related to the pending acquisition, which we expect to complete in the second half of 2027. On June 5, 2026, we entered into two option contracts to purchase or sell £2,793 million British pound sterling on or before February 8, 2028. We do not designate these derivative instruments as cash flow hedging instruments for accounting purposes; therefore, net changes to the derivative instruments’ fair value are included in Financing costs in our Condensed Consolidated Statements of Income. Based on our British pound sterling exposure at June 30, 2026, we estimate that a 10 percent decline in the value of the U.S. dollar against the British pound sterling would result in a foreign exchange gain for the derivative instruments of approximately $265 million in Financing costs, excluding the $47 million year-to-date loss recorded in Financing costs through June 30, 2026 in our Condensed Consolidated Statements of Income.
Read original filing text →As of the date of this report, there have been no material developments in the environmental proceedings related to our Bedford Park, Illinois manufacturing facility discussed in Part I, Item 3. Legal Proceedings in our Annual Report on Form 10-K for the year ended December 31,…
As of the date of this report, there have been no material developments in the environmental proceedings related to our Bedford Park, Illinois manufacturing facility discussed in Part I, Item 3. Legal Proceedings in our Annual Report on Form 10-K for the year ended December 31, 2025. In addition to the foregoing matter, we are currently subject to claims and suits arising in the ordinary course of business, including those relating to labor matters, certain environmental proceedings, and commercial claims. We also routinely receive inquiries from regulators and other government authorities relating to various aspects of our business, including with respect to compliance with laws and regulations relating to the environment, and at any given time, we have matters at various stages of resolution with the applicable governmental authorities. The outcomes of these matters are not within our complete control and may not be known for prolonged periods of time. We do not believe that the results of currently known legal proceedings and inquiries will be material to us. There can be no assurance, however, that such claims, suits, or investigations or those arising in the future, whether taken individually or in the aggregate, will not have a material adverse effect on our financial condition or results of operations.
Read original filing text →All material risk-factor changes relate to the pending Tate & Lyle acquisition, including deal-failure, integration, and leverage risks.